CONSUMER PERSPECTIVES ON AUSTRALIAN AND U.S. OVER-THE-COUNTER MEDICINE LABELLING STRATEGIES: IS STANDARDISATION THE WAY FORWARD?
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Presentation
- By: TONG, Vivien (The University Of Sydney, Faculty of Pharmacy, Sydney, Australia)
- Co-author(s): Vivien Tong
Over-the-counter (OTC) medicines require high quality labels to safeguard consumer use. Standardised Australian OTC labelling via the ’Medicine Information Box’ (MIB) format was recently proposed, modelled on the U.S. ‘Drug Facts’ label. However, limited research has explored consumer opinions on existing non-standardised Australian OTC labels,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.